HIGHLIGHTS
- who: Kensuke Suzuki et al. from the Department of Otolaryngology, Head and Neck Surgery, Kansai Medical University, Hirakata, Osaka, Japan have published the research work: Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model, in the Journal: (JOURNAL) of 30/08/2022
- what: This study used three different types of thyroid cancer cell lines, K1, FTC-133, and K1-NIS, which were obtained by transfection using the human NIS gene to K1 cells to investigate and compare the efficacy of CTLI against thyroid cancer cells with different profiling of NIS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.